ES8304559A1 - "procedimiento para la fabricacion de sales de naftidrofurilo". - Google Patents

"procedimiento para la fabricacion de sales de naftidrofurilo".

Info

Publication number
ES8304559A1
ES8304559A1 ES512819A ES512819A ES8304559A1 ES 8304559 A1 ES8304559 A1 ES 8304559A1 ES 512819 A ES512819 A ES 512819A ES 512819 A ES512819 A ES 512819A ES 8304559 A1 ES8304559 A1 ES 8304559A1
Authority
ES
Spain
Prior art keywords
naftidrofuryl
therapeutic use
citrate
naftidrofuryl citrate
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512819A
Other languages
English (en)
Other versions
ES512819A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9258433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8304559(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES8304559A1 publication Critical patent/ES8304559A1/es
Publication of ES512819A0 publication Critical patent/ES512819A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE SALES DE NAFTIDROFURILO, POR SALIFICACION DE LA BASE LIBRE, UTILIZANDO ACIDO CITRICO MONOHIDRATADO. CONSISTE EN LA REACCION DE ACETONA, ACETATO DE ETILO, NAFTIDROFURILO BASE Y ACIDO CITRICO MONOHIDRATADO, EN PROPORCION VOLUMETRICA DE ACETONA Y ACETATO DE ETILO 1:1, Y EN PROPORCIONES EQUIMOLECULARES DE NAFTIDROFURILO Y ACIDO CITRICO. LA MEZCLA DE REACCION SE SOMETE A CALENTAMIENTO A REFLUJO; POSTERIORMENTE SE ENFRIA A 5 C Y EL PRODUCTO OBTENIDO SE SEPARA POR FILTRACION. ESTE COMPUESTO TIENE APLICACIONES FARMACOLOGICAS POR SUS EFECTOS CARDIORESPIRATORIOS.
ES512819A 1981-05-14 1982-05-14 "procedimiento para la fabricacion de sales de naftidrofurilo". Granted ES512819A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8109590A FR2505836A1 (fr) 1981-05-14 1981-05-14 Citrate de naftidrofuryl et son application therapeutique

Publications (2)

Publication Number Publication Date
ES8304559A1 true ES8304559A1 (es) 1983-03-01
ES512819A0 ES512819A0 (es) 1983-03-01

Family

ID=9258433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512819A Granted ES512819A0 (es) 1981-05-14 1982-05-14 "procedimiento para la fabricacion de sales de naftidrofurilo".

Country Status (22)

Country Link
US (1) US4439442A (es)
EP (1) EP0065446B1 (es)
JP (1) JPS57203078A (es)
KR (1) KR830010091A (es)
AT (1) ATE9342T1 (es)
AU (1) AU8373282A (es)
CA (1) CA1184562A (es)
CS (1) CS239923B2 (es)
DD (1) DD202432A5 (es)
DE (1) DE3260712D1 (es)
DK (1) DK210982A (es)
ES (1) ES512819A0 (es)
FI (1) FI821664L (es)
FR (1) FR2505836A1 (es)
GR (1) GR75422B (es)
HU (1) HU187701B (es)
IL (1) IL65774A (es)
NZ (1) NZ200594A (es)
PT (1) PT74893B (es)
SU (1) SU1082323A3 (es)
YU (1) YU103082A (es)
ZA (1) ZA823195B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580502B1 (fr) * 1985-04-23 1988-07-08 Lipha Emploi du " naftidrofuryl " dans la preparation d'un medicament
TW200920348A (en) * 2007-06-28 2009-05-16 Dybly Ag Combination of picotamide with nafronyl
US8203109B2 (en) 2009-05-08 2012-06-19 Raytheon Company High energy laser beam director system and method
CN104086515A (zh) * 2014-06-13 2014-10-08 刘博� 萘呋胺酯草酸盐的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL142872C (es) * 1963-03-28
FR3843M (fr) * 1964-03-17 1966-01-17 Lipha Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.

Also Published As

Publication number Publication date
IL65774A0 (en) 1982-08-31
GR75422B (es) 1984-07-16
DK210982A (da) 1982-11-15
AU8373282A (en) 1982-11-18
PT74893A (fr) 1982-06-01
US4439442B1 (es) 1987-06-30
EP0065446B1 (fr) 1984-09-12
FI821664L (fi) 1982-11-15
SU1082323A3 (ru) 1984-03-23
DD202432A5 (de) 1983-09-14
CA1184562A (fr) 1985-03-26
ZA823195B (en) 1983-03-30
CS239923B2 (en) 1986-01-16
HU187701B (en) 1986-02-28
YU103082A (en) 1984-08-31
IL65774A (en) 1985-09-29
NZ200594A (en) 1985-03-20
US4439442A (en) 1984-03-27
DE3260712D1 (en) 1984-10-18
EP0065446A1 (fr) 1982-11-24
FI821664A0 (fi) 1982-05-11
FR2505836A1 (fr) 1982-11-19
JPS57203078A (en) 1982-12-13
KR830010091A (ko) 1983-12-26
ATE9342T1 (de) 1984-09-15
PT74893B (fr) 1983-12-23
FR2505836B1 (es) 1984-03-09
ES512819A0 (es) 1983-03-01

Similar Documents

Publication Publication Date Title
EP0460912A3 (en) Medicaments for the treatment of sexual disorder
EP0198092A4 (en) MAGNESIUM OR MAGNESIUM ALLOY WITH TREATED SURFACE, AND METHOD FOR TREATING THEIR SURFACE.
JPS56166378A (en) Treatment of titanium or titanium alloy article
MC1440A1 (fr) Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
US4439442B1 (es)
GR3006674T3 (es)
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
DE3071815D1 (en) Use of glycosylglucanes in the treatment of infections of the large intestines
PT78603B (en) Process for preparing 1,8-dihidroxy-10-acyl-9-anthrones especially for use in the treatment of psoriasis
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
IE811612L (en) Thiazoles
FR2517203B1 (fr) Composition pour le traitement de l'acne
ES8507552A1 (es) Un procedimiento para preparar 6-metilsulfonil-espiro-(croman-4,4'-imidazolidin)-2',5'-diona
IT1244562B (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.
AU6596080A (en) Treatment of disorders of calcium metabolism
IT8324208A0 (it) Procedimento per la riduzione del contenuto di ferro dei bagni di fosfatazione.
IT8322369A0 (it) Applicazione terapeutica delmazindolo nel trattamento delrussamento.
IT8785517A0 (it) Macchina per il trattamento in bagno delle pelli con giunto multiplo per il controllo totale del bagno.
IT8764232V0 (it) Macchina per il trattamento in bagno delle pelli con giunto multiplo per il controllo totale del bagno.
FR2686246B3 (fr) Orthese de poignet pour le traitement de l'epicondylalgie.
IT8421168V0 (it) Ferro per il trattamento delle callosita'.
IT8024828A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella terapia della iperlattacidemia.
PH25733A (en) 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders
MA19564A1 (fr) Derives de la pyrrolidine, sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
MX9203508A (es) 1,7-difenil-3-metilaza -7-ciano-8-metilnonano para usarse en el tratamiento de enfermedades.